Fibrogenesis in nonalcoholic steatohepatitis (Q37863130)

24 August 2017

1 reference

title

Fibrogenesis in nonalcoholic steatohepatitis (English)

1 reference

24 August 2017

0 references

Samuele De Minicis

1

1 reference

24 August 2017

Gianluca Svegliati-Baroni

series ordinal

2

1 reference

24 August 2017

publication date

1 April 2011

1 reference

Expert Review of Gastroenterology & Hepatology

24 August 2017

published in

1 reference

24 August 2017

volume

5

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

179-187

1 reference

Nonalcoholic fatty liver disease

24 August 2017

cites work

1 reference

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease

21 January 2018

1 reference

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

21 January 2018

1 reference

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.

21 January 2018

1 reference

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis

21 January 2018

1 reference

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Gene expression profiles during hepatic stellate cell activation in culture and in vivo

21 January 2018

1 reference

Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis

21 January 2018

1 reference

Formation and function of the myofibroblast during tissue repair

21 January 2018

1 reference

Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis

21 January 2018

1 reference

Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis.

21 January 2018

1 reference

CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury

21 January 2018

1 reference

Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model

21 January 2018

1 reference

The epithelial-mesenchymal transition: new insights in signaling, development, and disease

21 January 2018

1 reference

TGF-beta and epithelial-to-mesenchymal transitions

21 January 2018

1 reference

Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C.

21 January 2018

1 reference

Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C.

21 January 2018

1 reference

Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells

21 January 2018

1 reference

Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell

21 January 2018

1 reference

Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro

21 January 2018

1 reference

Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways

21 January 2018

1 reference

Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition.

21 January 2018

1 reference

Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice

21 January 2018

1 reference

Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation

21 January 2018

1 reference

Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice

21 January 2018

1 reference

The amazing universe of hepatic microstructure

21 January 2018

1 reference

Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers.

21 January 2018

1 reference

Cholangiocyte injury and ductopenic syndromes

21 January 2018

1 reference

Cell signaling. Fat stress and liver resistance

21 January 2018

1 reference

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

21 January 2018

1 reference

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

21 January 2018

1 reference

Leptin is essential for the hepatic fibrogenic response to chronic liver injury

21 January 2018

1 reference

Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells.

21 January 2018

1 reference

NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells

21 January 2018

1 reference

Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells

21 January 2018

1 reference

Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants

21 January 2018

1 reference

Vitamin C and vitamin E in prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in choline deficient diet fed rats

21 January 2018

1 reference

The superoxide-generating NADPH oxidase: structural aspects and activation mechanism

21 January 2018

1 reference

Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

Activation of the phagocyte NADPH oxidase by Rac Guanine nucleotide exchange factors in conjunction with ATP and nucleoside diphosphate kinase

21 January 2018

1 reference

The role of Kupffer cell oxidant production in early ethanol-induced liver disease.

21 January 2018

1 reference

21 January 2018

NOX in liver fibrosis

1 reference

Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis

21 January 2018

1 reference

Liver fibrogenesis: a new role for the renin-angiotensin system

21 January 2018

1 reference

NADPH oxidase in the liver: defensive, offensive, or fibrogenic?

21 January 2018

1 reference

Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis

21 January 2018

1 reference

Oxidants and antioxidants in alcohol-induced liver disease

21 January 2018

1 reference

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats

21 January 2018

1 reference

Oxidative stress-related molecules and liver fibrosis

21 January 2018

1 reference

Iron, oxidative stress and liver fibrogenesis

21 January 2018

1 reference

Histamine dihydrochloride protects against early alcohol-induced liver injury in a rat model

21 January 2018

1 reference

CD95 activation in the liver: ion fluxes and oxidative signaling

21 January 2018

1 reference

Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease

21 January 2018

1 reference

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

21 January 2018

1 reference

In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases

21 January 2018

1 reference

Insulin resistance in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation

21 January 2018

1 reference

Toll-like receptor signalling

21 January 2018

1 reference

Toll-like receptor signaling in the liver

21 January 2018

1 reference

Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4.

21 January 2018

1 reference

Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4.

21 January 2018

1 reference

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro.

21 January 2018

1 reference

Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms.

21 January 2018

1 reference

Involvement of PPAR nuclear receptors in tissue injury and wound repair

21 January 2018

1 reference

A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.

21 January 2018

1 reference

Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms

21 January 2018

1 reference

Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.

21 January 2018

1 reference

Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins.

21 January 2018

1 reference

The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity

21 January 2018

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice

21 January 2018

1 reference

Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin

21 January 2018

1 reference

Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis

21 January 2018

1 reference

Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis

21 January 2018

1 reference

Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.11.28

1 reference

24 August 2017

1 reference